Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up.
about
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanPathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndromePoly Cystic Ovarian Syndrome: An Updated OverviewScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Pharmacotherapy of polycystic ovary syndrome--an update.Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.Effect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat modelThe risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome.Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study.Genetic Predisposition to Polycystic Ovary Syndrome, Postpartum Weight Reduction, and Glycemic Changes: A Longitudinal Study in Women With Prior Gestational DiabetesCardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome.Glucose intolerance states in women with the polycystic ovary syndrome.PCOS in adolescence and type 2 diabetes.Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.[Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes.High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome.Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome.Prevalence of metabolic syndrome in women with polycystic ovary syndrome.The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.Diabetes risk in women with gestational diabetes mellitus and a history of polycystic ovary syndrome: a retrospective cohort study.Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study.Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.Alterations in Glucose Effectiveness and Insulin Dynamics: Polycystic Ovary Syndrome or Body Mass Index.Cardiometabolic risk in polycystic ovary syndrome.
P2860
Q21245262-0F1CF3E8-9EC2-42F9-930A-DF6EE776C694Q26738511-4E0DEA23-A85B-4D95-AC5A-D485E4D75EBDQ26752564-4C6C2807-0D27-4254-9E8F-0E83306306B3Q28390200-303C8B10-EFD9-471B-B5DE-E0D8FDC3B61DQ33569169-32F32104-0B59-4484-A318-D3CF8562F358Q33787190-77CB670C-03DB-47DC-94E6-858E4FD5CE0FQ34099068-1AD29707-177C-4AED-9FF3-5F217B020F70Q35051785-BD0AB011-E130-4B33-A3B8-E3B88615A27DQ35841226-CF9143C1-619B-41FD-975C-90732DA9D69FQ36182504-CD3E061E-4CF8-46C9-9D3E-72BFE6348E67Q36339954-0FA0A4C9-D5E4-4DA2-8033-DAFFC63CF20EQ36923491-03341739-83D8-4596-A063-1955E55AB01CQ37412812-0FF1798D-4E9F-4489-863D-F14C457EB2CEQ37689166-55787611-1556-427E-9D6B-6057137F7462Q38150697-B9459D9A-EB95-47C7-965D-CE40D76C9A5CQ38268267-A6412564-67C3-4349-9E17-8A4A9582250FQ39852410-A641D870-C3C9-4F9D-A0EA-686D88CC1CCDQ40404052-715E43B9-8CF3-4F25-B575-D567A5B2F6ABQ40946230-01C53B2C-6CFE-407E-9A1D-B5A52808532AQ42756479-11A0A0C0-25E8-461C-8E7F-6125246E7839Q44563345-A691F111-7FDC-4992-B43C-09066F950988Q45330793-70F57EDA-1C63-4CD1-8A3A-B61A8DC34BABQ45357741-98A436D6-829E-498E-85D2-29A38A4888A6Q47181603-F6CBF198-A90A-45E7-A4FF-E2345D39DDC7Q48282250-5464A665-BE9C-4C7E-8794-28443778E8B2Q50548329-B2DDE04C-4AC0-47B0-834F-E5F0A412B8C9Q50880377-1A20472F-1161-4251-8460-087B5726C3A0Q51011840-C97F9389-1E8C-4336-A57E-62A51DDE062CQ51267146-3DC678EF-DD34-4A0D-9214-B46B472E4B2EQ55437110-7D485353-BBAD-4FEB-94A4-7C9E522B74D5
P2860
Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Risk of T2DM and impaired fast ...... esults of an 8-year follow-up.
@en
Risk of T2DM and impaired fast ...... esults of an 8-year follow-up.
@nl
type
label
Risk of T2DM and impaired fast ...... esults of an 8-year follow-up.
@en
Risk of T2DM and impaired fast ...... esults of an 8-year follow-up.
@nl
prefLabel
Risk of T2DM and impaired fast ...... esults of an 8-year follow-up.
@en
Risk of T2DM and impaired fast ...... esults of an 8-year follow-up.
@nl
P2093
P2860
P1476
Risk of T2DM and impaired fast ...... esults of an 8-year follow-up.
@en
P2093
Kevin E Kip
Monique Y Boudreaux
Selma F Witchel
P2860
P2888
P356
10.1007/S11892-006-0056-1
P577
2006-02-01T00:00:00Z